A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults
Clinical trial NCT04844775 · COMPLETED
Trial details
- NCT number
- NCT04844775
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-05
- Primary completion
- 2024-09-09
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.